Compass Therapeutics, Inc. (CMPX)
0.7443
-0.01
(-1.57%)
USD |
NASDAQ |
Oct 30, 10:33
Compass Therapeutics Price to Book Value : 0.8072 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 0.8201 |
| October 28, 2026 | 0.8246 |
| October 27, 2026 | 0.8106 |
| October 26, 2026 | 0.8104 |
| October 23, 2026 | 0.8253 |
| October 22, 2026 | 0.8693 |
| October 21, 2026 | 0.8834 |
| October 20, 2026 | 0.9038 |
| October 19, 2026 | 0.9056 |
| October 16, 2026 | 0.9327 |
| October 15, 2026 | 0.9725 |
| October 14, 2026 | 0.9533 |
| October 13, 2026 | 0.9295 |
| October 12, 2026 | 1.017 |
| October 09, 2026 | 1.077 |
| October 08, 2026 | 1.066 |
| October 07, 2026 | 1.106 |
| October 06, 2026 | 1.082 |
| October 05, 2026 | 1.042 |
| October 02, 2026 | 0.9291 |
| October 01, 2026 | 0.9773 |
| September 30, 2026 | 1.128 |
| September 29, 2026 | 1.193 |
| September 28, 2026 | 1.204 |
| September 25, 2026 | 1.226 |
| Date | Value |
|---|---|
| September 24, 2026 | 1.231 |
| September 23, 2026 | 1.269 |
| September 22, 2026 | 1.345 |
| September 21, 2026 | 1.974 |
| September 18, 2026 | 2.061 |
| September 17, 2026 | 2.006 |
| September 16, 2026 | 1.985 |
| September 15, 2026 | 2.006 |
| September 14, 2026 | 2.126 |
| September 11, 2026 | 2.169 |
| September 10, 2026 | 2.223 |
| September 09, 2026 | 2.364 |
| September 08, 2026 | 2.397 |
| September 04, 2026 | 2.581 |
| September 03, 2026 | 2.570 |
| September 02, 2026 | 2.636 |
| September 01, 2026 | 2.505 |
| August 31, 2026 | 2.592 |
| August 28, 2026 | 2.603 |
| August 27, 2026 | 2.733 |
| August 26, 2026 | 2.636 |
| August 25, 2026 | 2.744 |
| August 24, 2026 | 2.603 |
| August 21, 2026 | 2.603 |
| August 20, 2026 | 2.560 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Viking Therapeutics, Inc. | 5.834 |
| Capricor Therapeutics, Inc. | 1.466 |
| Ardelyx, Inc. | 4.957 |
| Biomea Fusion, Inc. | 3.675 |
| ARS Pharmaceuticals, Inc. | 27.89 |
Price to Book Value Related Metrics
| Price | 0.7443 |
| Earnings Yield | -54.08% |
| Market Cap | 134.04M |